| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |